Related references
Note: Only part of the references are listed.Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
Ralf Pasternack et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Inhibitors of blood coagulation factor XIII
Thomas Schmitz et al.
ANALYTICAL BIOCHEMISTRY (2020)
N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence
Boglarka Hurjak et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Sophie Testa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins
Woosuk S. Hur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Let's cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A
J. L. Mitchell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema
Jingxuan Liu et al.
RNA (2019)
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
Jayesh A. Kulkarni et al.
ACS NANO (2018)
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition
Alisa S. Wolberg
CURRENT OPINION IN HEMATOLOGY (2018)
Auto- and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences
L. Muszbek et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX
Sandra Le Quellec et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
Sravya Kattula et al.
BLOOD ADVANCES (2018)
Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice
Rikke Stagaard et al.
BLOOD ADVANCES (2018)
Minimal factor XIII activity level to prevent major spontaneous bleeds
M. Menegatti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients
Akitada Ichinose
BLOOD REVIEWS (2017)
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Sam Chen et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism
S. A. Shaya et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Thrombolysis by chemically modified coagulation factor Xa
E. L. G. Pryzdial et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Newly-Recognized Roles of Factor XIII in Thrombosis
James R. Byrnes et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
(±) cis-bisamido epoxides: A novel series of potent FXIII-A inhibitors
Craig A. Avery et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification
Masato Yuasa et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Alfica Sehgal et al.
NATURE MEDICINE (2015)
Cystamine Preparations Exhibit Anticoagulant Activity
Maria M. Aleman et al.
PLOS ONE (2015)
Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion
Harini Raghu et al.
BLOOD (2015)
Functional factor XIII-A is exposed on the stimulated platelet surface
Joanne L. Mitchell et al.
BLOOD (2014)
Factor XIII activity mediates red blood cell retention in venous thrombi
Maria M. Aleman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Structure of Active Coagulation Factor XIII Triggered by Calcium Binding: Basis for the Design of Next-Generation Anticoagulants
Martin Stieler et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production
Huma Safdar et al.
BLOOD (2013)
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
New developments in the management of congenital Factor XIII deficiency
Zehra Fadoo et al.
JOURNAL OF BLOOD MEDICINE (2013)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
Aida Inbal et al.
BLOOD (2012)
Factor XIII, clot structure, thrombosis
Zsuzsa Bagoly et al.
THROMBOSIS RESEARCH (2012)
The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linking
Steven R. Fraser et al.
BLOOD (2011)
An update of the mutation profile of Factor 13 A and B genes
Arijit Biswas et al.
BLOOD REVIEWS (2011)
FACTOR XIII: A COAGULATION FACTOR WITH MULTIPLE PLASMATIC AND CELLULAR FUNCTIONS
Laszlo Muszbek et al.
PHYSIOLOGICAL REVIEWS (2011)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency
Eva Ajzner et al.
BLOOD (2009)
Reference gene selection for real-time RT-PCR in regenerating mouse livers
Kohei Tatsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
J. S. Palumbo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice
Masayoshi Souri et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
International Registry on Factor XIII Deficiency: A basis formed mostly on European data
Vytautas Ivaskevicius et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Elevated factor XIII level and the risk of myocardial infarction in women
Zsuzsanna Bereczky et al.
HAEMATOLOGICA (2007)
Factor XIII and the clotting of fibrinogen: from basic research to medicine
L Lorand
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: Hemostatic abnormalities in mutant mice and characterization of the coagulation deficit
P Lauer et al.
THROMBOSIS AND HAEMOSTASIS (2002)
Transglutaminases: Nature's biological glues
M Griffin et al.
BIOCHEMICAL JOURNAL (2002)
Share Paper
